Novavax Gains After U.K. Vaccine Study Fully Enrolled

(Bloomberg) -- Novavax Inc.’s stock reversed an premarket drop to climb as much as 6.6% following other companies developing Covid-19 vaccines higher after the company said a study in the U.K. reac...